Brokerages Set UiPath, Inc. (NYSE:PATH) PT at $13.21

UiPath, Inc. (NYSE:PATH) has been assigned a consensus rating of “Hold” from the eighteen brokerages that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, twelve have issued a hold recommendation, two have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $13.2143.

Several equities analysts recently issued reports on PATH shares. BMO Capital Markets boosted their price target on shares of UiPath from $12.50 to $13.00 and gave the company a “market perform” rating in a research report on Thursday, October 2nd. Zacks Research upgraded shares of UiPath from a “hold” rating to a “strong-buy” rating in a report on Monday, September 8th. Weiss Ratings restated a “sell (d)” rating on shares of UiPath in a report on Wednesday, October 8th. Cowen restated a “hold” rating on shares of UiPath in a report on Friday, September 5th. Finally, DA Davidson assumed coverage on shares of UiPath in a report on Friday, September 5th. They issued a “neutral” rating and a $12.00 price objective on the stock.

UiPath Price Performance

Shares of NYSE PATH opened at $17.15 on Friday. UiPath has a 1 year low of $9.38 and a 1 year high of $18.74. The company’s 50-day moving average is $12.11 and its 200 day moving average is $12.08. The stock has a market capitalization of $9.11 billion, a P/E ratio of 571.63, a P/E/G ratio of 6.31 and a beta of 1.07.

UiPath (NYSE:PATH) last announced its quarterly earnings results on Thursday, September 4th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.07. UiPath had a net margin of 1.35% and a return on equity of 1.28%. The company had revenue of $361.73 million for the quarter, compared to analysts’ expectations of $347.36 million. During the same quarter in the previous year, the company earned $0.04 earnings per share. UiPath’s quarterly revenue was up 14.6% on a year-over-year basis. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. Research analysts anticipate that UiPath will post -0.17 earnings per share for the current year.

Insider Buying and Selling

In other news, CEO Daniel Dines sold 122,734 shares of the stock in a transaction that occurred on Friday, October 10th. The shares were sold at an average price of $18.37, for a total transaction of $2,254,623.58. Following the sale, the chief executive officer owned 490,936 shares in the company, valued at $9,018,494.32. This represents a 20.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Brad Brubaker sold 66,665 shares of the stock in a transaction that occurred on Monday, October 6th. The shares were sold at an average price of $15.00, for a total transaction of $999,975.00. Following the sale, the insider owned 690,519 shares in the company, valued at approximately $10,357,785. The trade was a 8.80% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 1,725,068 shares of company stock worth $22,742,192. Corporate insiders own 23.19% of the company’s stock.

Institutional Investors Weigh In On UiPath

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Patriot Financial Group Insurance Agency LLC boosted its stake in shares of UiPath by 249.2% during the 3rd quarter. Patriot Financial Group Insurance Agency LLC now owns 75,050 shares of the company’s stock worth $1,004,000 after acquiring an additional 53,555 shares during the last quarter. Silverberg Bernstein Capital Management LLC purchased a new position in shares of UiPath during the 3rd quarter worth $165,000. Graphene Investments SAS boosted its stake in shares of UiPath by 4.4% during the 3rd quarter. Graphene Investments SAS now owns 224,600 shares of the company’s stock worth $3,005,000 after acquiring an additional 9,400 shares during the last quarter. American Trust purchased a new position in shares of UiPath during the 2nd quarter worth $148,000. Finally, Total Investment Management Inc. purchased a new position in shares of UiPath during the 2nd quarter worth $108,000. Hedge funds and other institutional investors own 62.50% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.